Skip to main navigation Skip to search Skip to main content

Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia

  • Irene M. Ghobrial
  • , Federico Campigotto
  • , Timothy J. Murphy
  • , Erica N. Boswell
  • , Ranjit Banwait
  • , Feda Azab
  • , Stacey Chuma
  • , Janet Kunsman
  • , Amanda Donovan
  • , Farzana Masood
  • , Diane Warren
  • , Scott Rodig
  • , Kenneth C. Anderson
  • , Paul G. Richardson
  • , Edie Weller
  • , Jeffrey Matous
  • Harvard University
  • University of Colorado Colorado Springs
  • Brigham and Women's Hospital

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume121
Issue number8
DOIs
StatePublished - Feb 21 2013
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Gastroenterology
  • Surgery
  • Internal Medicine

Cite this